• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

We must address the MASLD awareness gap, improve educational quality and prepare for the digitally quantified self.

作者信息

Kopka Christopher J, Pugliese Nicola, Brennan Paul N, Lazarus Jeffrey V

机构信息

Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.

Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Italy.

出版信息

Liver Int. 2024 Sep;44(9):2099-2101. doi: 10.1111/liv.15951.

DOI:10.1111/liv.15951
PMID:39205464
Abstract
摘要

相似文献

1
We must address the MASLD awareness gap, improve educational quality and prepare for the digitally quantified self.我们必须填补对代谢相关脂肪性肝病（MASLD）的认知空白，提高教育质量，并为数字化自我量化做好准备。
Liver Int. 2024 Sep;44(9):2099-2101. doi: 10.1111/liv.15951.
2
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD.代谢相关脂肪性肝病时代非侵入性评分和血清生物标志物在脂肪性肝病中的应用：从非酒精性脂肪性肝病到代谢相关脂肪性肝病和脂肪性肝病的综合评价。
Curr Obes Rep. 2024 Sep;13(3):510-531. doi: 10.1007/s13679-024-00574-z. Epub 2024 May 29.
3
Fatty Liver Disease: Enter the Metabolic Era.脂肪肝疾病：进入代谢时代。
Curr HIV/AIDS Rep. 2023 Dec;20(6):405-418. doi: 10.1007/s11904-023-00669-7. Epub 2023 Oct 26.
4
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.代谢相关脂肪性肝病和非酒精性脂肪性肝病的临床特征和病死率相似。
J Hepatol. 2024 May;80(5):694-701. doi: 10.1016/j.jhep.2024.01.014. Epub 2024 Jan 27.
5
Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease.代谢相关脂肪性肝病与冠状动脉 CT 血管造影结果的预后价值比较：与非酒精性脂肪肝的比较。
Cardiovasc Diabetol. 2024 May 10;23(1):167. doi: 10.1186/s12933-024-02268-1.
6
Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States.食物不安全、家庭收入低和教育程度低会增加美国青少年发生代谢相关脂肪性肝病的风险。
Am J Gastroenterol. 2024 Jun 1;119(6):1089-1101. doi: 10.14309/ajg.0000000000002749. Epub 2024 Mar 13.
7
Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes.代谢相关脂肪性肝病的多基因风险评分增加了严重肝脏疾病和代谢相关结局的健康影响。
J Transl Med. 2024 Jul 12;22(1):650. doi: 10.1186/s12967-024-05478-z.
8
Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction.根据 MRI 衍生质子密度脂肪分数在健康检查中命名法的变化，非酒精性脂肪性肝病、代谢相关脂肪性肝病和代谢相关脂肪性肝炎的患病率存在差异。
Abdom Radiol (NY). 2024 Sep;49(9):3036-3044. doi: 10.1007/s00261-024-04285-w. Epub 2024 Apr 8.
9
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease.脂肪性肝病新命名法的意义及代谢相关脂肪性肝病的定义。
Aliment Pharmacol Ther. 2024 Jan;59(2):150-156. doi: 10.1111/apt.17846.
10
Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study.经活检证实的脂肪性肝病和脂肪性肝炎患者的循环激素：一项多中心观察性研究。
Metabolism. 2023 Nov;148:155694. doi: 10.1016/j.metabol.2023.155694. Epub 2023 Sep 25.

引用本文的文献

1
Lights and Shadows of a Vegetarian Diet in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病患者素食的利弊
Nutrients. 2025 May 12;17(10):1644. doi: 10.3390/nu17101644.